Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1033
-
Peripheral blood cytopenia before treatment in HCV patients: is it a limitation for HCV treatment in the era of DAA?Bourlière, Marc et al. | 2012
- 1037
-
BCLC – now also an internationally acclaimed prognostic system?Peck‐Radosavljevic, Markus / Stauber, Rudolf E. et al. | 2012
- 1039
-
Hypoxic hepatitisHenrion, Jean et al. | 2012
- 1053
-
The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011Song, Peipei / Tobe, Ruoyan G. / Inagaki, Yoshinori et al. | 2012
- 1064
-
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancerTu, Wei / Luo, Min / Wang, Zhijun et al. | 2012
- 1079
-
Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosisLockman, Khalida A. / Baren, James P. / Pemberton, Christopher J. et al. | 2012
- 1093
-
Effect of RhoA on transforming growth factor β1‐induced rat hepatic stellate cell migrationLi, Lei / Wang, Ji‐Yao / Yang, Chang‐Qing et al. | 2012
- 1103
-
β‐2 Spectrin is involved in hepatocyte proliferation through the interaction of TGFβ/Smad and PI3K/AKT signallingWang, Zhijun / Song, Yuhu / Tu, Wei et al. | 2012
- 1112
-
A rare cause of massive hepatomegalyTariciotti, Laura / Platto, Marco / Bramhall, Simon R. et al. | 2012
- 1113
-
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapyGiannini, Edoardo G. / Marenco, Simona / Fazio, Valentina et al. | 2012
- 1120
-
Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long‐term clinical outcomes of 1717 treatment‐naïve patients with hepatocellular carcinomaKim, Beom Kyung / Kim, Seung Up / Park, Jun Yong et al. | 2012
- 1128
-
Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatmentRana, Deepa / Chawla, Yogesh K. / Duseja, Ajay et al. | 2012
- 1138
-
Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantationTodd Stravitz, R. / Shiffman, Mitchell L. / Kimmel, Melissa et al. | 2012
- 1146
-
Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinomaMizuno, Hideki / Honda, Masao / Shirasaki, Takayoshi et al. | 2012
- 1156
-
Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal liversXu, Jing / Igarashi, Saya / Sasaki, Motoko et al. | 2012
- 1165
-
The significance of ICG‐R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinomaYoon, Hong In / Koom, Woong Sub / Lee, Ik Jae et al. | 2012
- 1172
-
MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus‐related hepatocellular carcinoma in a northeast Han Chinese populationWang, Xi / Zhang, Xuelong / Qiu, Bing et al. | 2012
- 1179
-
Lamivudine plus adefovir vs. entecavir in HBeAg‐positive hepatitis B with sequential treatment failure of lamivudine and adefovirSon, Chang Young / Ryu, Han Jak / Lee, Jung Min et al. | 2012
- 1186
-
ADMA and hepatic endothelial dysfunction in cirrhosis – the DDAH isoform is the keyMookerjee, Rajeshwar P. / Balasubramaniyan, Vairappan / Mehta, Gautam et al. | 2012
- 1187
-
Response to the‐ADMA and hepatic endothelial dysfunction in cirrhosis‐the DDAH isoform is the keyYang, Ying‐Ying / Lin, Han‐Chieh et al. | 2012
- 1188
-
Neutrophil to lymphocyte ratio: a hopeful marker predicting the disease severity in patients with nonalcoholic fatty liver diseaseCelikbilek, Mehmet / Dogan, Serkan / Yurci, Alper et al. | 2012
- 1189
-
Noninvasive assessment of the effect of treatment in nonalcoholic fatty liver disease: neutrophil to lymphocyte ratioDogan, Serkan / Celikbilek, Mehmet / Yagbasan, Ahmet et al. | 2012
- 1189
-
Usefulness of neutrophil to lymphocyte ratio in fatty liver disease: authors' replyAlkhouri, Naim / Campbell, Carla / Zein, Nizar N. et al. | 2012